PEMT

Chr 17

phosphatidylethanolamine N-methyltransferase

Also known as: PEAMT, PEMPT, PEMT2, PLMT

Phosphatidylcholine (PC) is the most abundant mammalian phospholipid. This gene encodes an enzyme which converts phosphatidylethanolamine to phosphatidylcholine by sequential methylation in the liver. Another distinct synthetic pathway in nucleated cells converts intracellular choline to phosphatidylcholine by a three-step process. The protein isoforms encoded by this gene localize to the endoplasmic reticulum and mitochondria-associated membranes. Alternate splicing of this gene results in multiple transcript variants encoding different isoforms. [provided by RefSeq, May 2012]

ResearchGenerating clinical summary…
MultiplemechanismLOEUF 0.67
Clinical SummaryPEMT
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.26) despite low pLI — interpret in context.
💊
Clinical Trials
12 active or recruiting trials — potential therapeutic options may be available
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.67LOEUF
pLI 0.235
Z-score 2.35
OE 0.26 (0.120.67)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
-0.11Z-score
OE missense 1.03 (0.901.18)
142 obs / 138.3 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.26 (0.120.67)
00.351.4
Missense OE?1.03 (0.901.18)
00.61.4
Synonymous OE?1.03
01.21.6
LoF obs/exp: 3 / 11.6Missense obs/exp: 142 / 138.3Syn Z: -0.19

This gene — mechanism propensity

DN
0.6938th %ile
GOF
0.77top 25%
LOF
0.2581th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

PEMT · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

Inflammatory Bowel DiseasesCrohn Disease

Predicting IBD Treatment Outcomes With Gut Microbiome Analysis

RECRUITING
NCT06453720University of British ColumbiaStarted 2024-08-01
Colonoscopy
Breast Cancer

Anti-Inflammatory Diet in BRC Patients on Aromatase Inhibitors

RECRUITING
NCT06214598Phase NAUniversity of BelgradeStarted 2024-03-01
SupplementAI dietPlacebo
Anaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveApocrine Carcinoma

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

ACTIVE NOT RECRUITING
NCT02978625Phase PHASE2National Cancer Institute (NCI)Started 2017-09-27
Biopsy ProcedureBiospecimen CollectionComputed Tomography
Breast Cancer MetastaticBreast Carcinoma

Immun Checkpoint Washout in Patients With Invasive Ductal Breast Cancer

RECRUITING
NCT07003009Phase NAIstanbul Training and Research HospitalStarted 2024-01-01
Malign Lymph Node WashoutBenign Lymph Node Washout
Inflammatory Bowel Disease (IBD)

Personalized Exercise Coaching to Improve Quality of Life in Pediatric IBD

ACTIVE NOT RECRUITING
NCT07355101Phase NAUniversiteit AntwerpenStarted 2025-11-01
Intake session to define individualized physical activity goalsPersonalized Motivational Coaching24 Week Exercise Programme
Multiple Myeloma

A Clinical Study of TQB2029 for Injection in Subjects With Multiple Myeloma

RECRUITING
NCT06700395Phase PHASE1Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.Started 2024-11-28
TQB2029 injection
Malignant NeoplasmOrgan Damage

Construction and Evaluation of Tumor Immunotherapy and Organ Damage Early Warning System Based on Multi-omics

RECRUITING
NCT07131007Hebei Medical University Fourth HospitalStarted 2025-09-15
Immunotherapy Monitoring and Sample Collection
Sinusitis, ChronicSinus DiseaseSinus Infection

Microbiota Transfer for Chronic Rhinosinusitis

ACTIVE NOT RECRUITING
NCT05454072Phase NAAmin JaverStarted 2022-06-15
Sinonasal Microbiota TransferSham Sinonasal Microbiota Transfer
Type1diabetes

Crosstalk Between Mucosal-Associated Invariant T (MAIT) Cells and the Gut Microbiota and Mucosa in the Development of Type 1 Diabetes in Children

RECRUITING
NCT05054361Institut National de la Santé Et de la Recherche Médicale, FranceStarted 2022-01-01
MAIT cells analysisMAIT cytokines production analysisLactulose/Mannitol Test
Hypertension, Resistant to Conventional Therapy

Antihypertensive Mechanisms of Minocycline in Resistant Hypertension

RECRUITING
NCT06246396Phase PHASE4University of FloridaStarted 2025-01-08
Minocycline HydrochloridePlacebo
Breast Cancer

Impact Of Intermittent And Water-Only Fasting On Gene Expression And Tumor Markers In Breast Cancer

ACTIVE NOT RECRUITING
NCT07440784Phase NAKhyber Medical University PeshawarStarted 2022-08-01
Conventional ChemotherapyIntermittent Fasting (23:1 Regimen)Ketogenic Diet
Mucin B5 rs (35705950) Gene Polymorphism in Interstitial Lung Diseases

MucinB5 Gene Polymorphism and Leucocytes Telomere Length in Interstitial Lung Diseases

RECRUITING
NCT06498141Sohag UniversityStarted 2023-10-01